Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.

Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW.

Lancet. 2008 Sep 20;372(9643):1065-72. doi: 10.1016/S0140-6736(08)61448-8.

2.

Asthma control and future asthma-related morbidity in inner-city asthmatic children.

Kwong KY, Morphew T, Scott L, Guterman J, Jones CA.

Ann Allergy Asthma Immunol. 2008 Aug;101(2):144-52. doi: 10.1016/S1081-1206(10)60202-5.

PMID:
18727469
3.

Polygenes, risk prediction, and targeted prevention of breast cancer.

Pharoah PD, Antoniou AC, Easton DF, Ponder BA.

N Engl J Med. 2008 Jun 26;358(26):2796-803. doi: 10.1056/NEJMsa0708739.

4.

Expert Panel Report 3: Moving forward to improve asthma care.

Busse WW, Lemanske RF Jr.

J Allergy Clin Immunol. 2007 Nov;120(5):1012-4. No abstract available.

PMID:
17983868
5.

Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients.

Sullivan SD, Wenzel SE, Bresnahan BW, Zheng B, Lee JH, Pritchard M, Kamath TV, Weiss ST; TENOR Study Group.

Allergy. 2007 Jun;62(6):655-60.

6.

Does sputum eosinophilia predict the response to systemic corticosteroids in children with difficult asthma?

Lex C, Jenkins G, Wilson NM, Zacharasiewicz A, Erin E, Hansel TT, Bush A, Payne DN.

Pediatr Pulmonol. 2007 Mar;42(3):298-303.

PMID:
17262857
7.

Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests.

Lex C, Ferreira F, Zacharasiewicz A, Nicholson AG, Haslam PL, Wilson NM, Hansel TT, Payne DN, Bush A.

Am J Respir Crit Care Med. 2006 Dec 15;174(12):1286-91. Epub 2006 Sep 14.

PMID:
16973985
8.

Recent asthma exacerbations: a key predictor of future exacerbations.

Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group.

Respir Med. 2007 Mar;101(3):481-9. Epub 2006 Aug 17.

9.

Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.

Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N.

Chest. 2006 Jun;129(6):1492-9.

PMID:
16778266
10.

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.

Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID.

Clin Exp Allergy. 2005 Sep;35(9):1175-9.

PMID:
16164444
11.

Standardisation of spirometry.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Aug;26(2):319-38. No abstract available.

12.

Impact of depressive symptoms on adult asthma outcomes.

Eisner MD, Katz PP, Lactao G, Iribarren C.

Ann Allergy Asthma Immunol. 2005 May;94(5):566-74.

PMID:
15948301
13.

Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.

Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E; Asthma Clinical Research Network, National Heart, Lung, and Blood Institute/NIH.

J Allergy Clin Immunol. 2005 Apr;115(4):720-7.

PMID:
15805990
14.

Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity.

Gruchalla RS, Pongracic J, Plaut M, Evans R 3rd, Visness CM, Walter M, Crain EF, Kattan M, Morgan WJ, Steinbach S, Stout J, Malindzak G, Smartt E, Mitchell H.

J Allergy Clin Immunol. 2005 Mar;115(3):478-85.

PMID:
15753892
15.

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.

Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC.

Thorax. 2005 Mar;60(3):215-8.

16.

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, Khan M, Bush A.

Am J Respir Crit Care Med. 2005 May 15;171(10):1077-82. Epub 2005 Feb 11.

PMID:
15709050
17.

The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.

Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ.

J Allergy Clin Immunol. 2004 Nov;114(5):1241-56.

PMID:
15536442
18.

Results of a home-based environmental intervention among urban children with asthma.

Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R 3rd, Stout J, Malindzak G, Smartt E, Plaut M, Walter M, Vaughn B, Mitchell H; Inner-City Asthma Study Group.

N Engl J Med. 2004 Sep 9;351(11):1068-80.

19.

Exhaled nitric oxide predicts asthma exacerbation.

Harkins MS, Fiato KL, Iwamoto GK.

J Asthma. 2004 Jun;41(4):471-6.

PMID:
15281333
20.

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF, Bao W, Fowler-Taylor A, Matthews J, Busse WW, Holgate ST, Fahy JV.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. Epub 2004 Jun 1.

PMID:
15172898

Supplemental Content

Support Center